Lymphocytic Leukemia, Chronic, B Cell
2 clinical trials · Condition
◉ Watch Lymphocytic Leukemia, Chronic, B Cell
| Record | Firm | Date |
|---|---|---|
| Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT03204188) | National Heart, Lung, and Blood Institute (NHLBI) | 2017-09-22 |
Track Lymphocytic Leukemia, Chronic, B Cell automatically
Every clearance here is in the API, with alerts when new ones post.